TABLE 4.
Severity outcomes at T14 and T30 for RSV‐A and RSV‐B subgroups. Patients with missing subtype characterization and with positivity for both A and B subtypes were excluded. Variables with a * have a statistically significant difference.
| Follow‐up |
RSV‐A T14 n = 53 T30 n = 38 |
RSV‐B T14 n = 157 T30 n = 142 |
|
|---|---|---|---|
| Persistence of symptoms | T14 | 28 | 71 |
| T30 | 7 | 26 | |
| Further pediatric examination* | T14 | 36 | 109 |
| T30* | 11 | 16 | |
| Emergency department access | T14 | 7 | 16 |
| T30 | 3 | 2 | |
| Hospitalization | T14 | 2 | 2 |
| T30 | 2 | 0 | |
| Complications | T30 | 4 | 9 |
Note: Bold indicates statistically significant variable.